您要查找的是不是:
- Tumor size, pTNM, vascular invasion and MILAN-criteria were risk factors of tumor recurrence, and so that affecting the tumor free survival. 肿瘤的大小、TNM分期、有无脉管浸润、是否符合Milan标准均能反映肿瘤复发的风险,而肿瘤的TNM分期及肿瘤有无脉管浸润能进一步影响患者术后的无瘤存活率。
- CT26 colorectal adenocarcinoma-bearing mice model were established and treated with the tumor specific CTL, the tumor size and the survival period of mice were monitored. 建立CT26荷瘤小鼠模型,应用CTL治疗荷瘤小鼠,观察肿瘤大小和小鼠存活期。
- The patient has been kept tumor free for more than 13 months. 病人于术后十三个月仍无肿瘤复发或转移的现象。
- Patients with poor prognosis had a shorter progression period and shorter disease free survival period. They needed more chemotherapy treatment, and maintenance treatment. 未得到良好治疗的病人疾病发展更迅速,生存机会更小。他们需要更多的化学治疗和维持治疗。
- The preliminary result suggested that AHSCT could prolong the disease - free survival for AL, HD and ALC. 初步结果提示AHSCT能延长AL、HD和ALC患者的无病存活期。
- Interferon could significantly prolong the chr onic period and survival period of CGL patients. 干扰素有助于延长CGL患者慢性期及生存期,延缓急变的发生。
- The 3-year overall survival (OS) and disease free survival ( DFS) was 66. 3% and 59. 5% , respectively. 3年总生存率和无病生存率分别为66.;3%25和59
- Palliative operation and surgery for perforated gastric carcinoma will prolong survival period of the patient with AGC. 姑息性胃癌切除术和胃癌穿孔的积极手术治疗,可以延长患者的生存期。
- The 5 -year overall survival (OS) and disease free survival (DFS) were 89% and 73%,respectively. 全组5年总生存率和无病生存率分别为89%25和73%25。
- Mice implanted with these induced pluripotent stem cells remained tumor free after six months, according to the study published online in Science Express. 根据在线发表ScienceExpress上的研究结果,植入了这种多能干细胞的小鼠在六个月后仍未患肿瘤。
- Long-term results of RCT plus TCM is increasing survival rate of cancer patients and prolonging their survival period. 中西医结合治疗减轻了癌症患者在放化疗中的近期毒副作用,提高了疗效及生活质量,远期提高癌症患者的生存率、延长了生存时间。
- The five-year survival rate (SR),disease free survival rate (DFSR) were 65 6% and 54 5%,respectively. 总的5年生存率、无瘤生存率分别为65.;6%25和54
- The study aimed to show a 35% increase in progression free survival when the MabThera-based combination was used. 研究表明使用基于美罗华的联合治疗,可以将无进展生存提高35%25。
- Masothelioma,a rare tumor,usually occurred in pleura,peritoneum and cardiac pericardium and so on.The majority is malignant,with short surviving period and high mortality. 间皮瘤是发生于胸膜、腹膜、心包膜等处的一罕见肿瘤,多为恶性且生存期短,死亡率高。
- Results 35 completely relieved, 7 partials relieved, 5 aggravated, 5 no effect, the average survival period was 15 months. 结果完全缓解35例,部分缓解7例,无变化5例,进展5例,无围手术期死亡病例,平均生存期15个月。
- Univariate analysis showed that patients with low expression of VEGF and MVD had longer disease free survival (DFS) and overall suvival(OS). 单因素预后分析显示,VEGF及MVD低表达者无病生存期(DFS)及总生存期(OS)长于高表达者。
- Conclusion Intrapericardial total pneumonectomy is safe,it can raise the pulmonary resection rate and prolong the survival period of the patients. 结论 经心包内处理肺血管全肺切除术安全性较好,可提高肺癌切除率、延长术后生存期。
- METHODS:The mRNA expression levels of IGF 1/IGF 1R were assessed by RT PCR method in the gastric cancer tissues, adjacent mucosa and tumor free tissues from 28 patients with gastric carcinoma and the normal gastric mucosa from 14 healthy controls. 方法 :对 2 8例经手术切除并由病理证实的胃癌患者的癌、癌旁及胃黏膜正常区组织标本进行研究 ,以 14例正常人胃黏膜标本作对照 ,应用RT PCR方法 ,检测IGF 1/IGF 1R在胃癌组织与正常人胃黏膜中的表达变化和胃癌患者的癌、癌旁及胃黏膜正常区组织中的表达变化。
- The patient of OSCC with high PCNA expression had a shorter survival period than that with low PCNA expression(P=0.013). PCNA高表达者术后生存期短于低表达者(P=0.;013)。
- The average survival period of perforation repair, partial gastrectomy radical gastrectomy, is 9.5 months 14 months and 26.2 months respectively. 穿孔修补、姑息性切除和胃癌根治后平均生存期分别为9.;5个月、14个月、26